Lipid Management in Children

Endocrinology and Metabolism Clinics of North America

Volumn 38, Issue 1, 2009, Pages 171-183

  Zappalla, Frances R ^a   Gidding, Samuel S ^a  

^a NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

Atherosclerosis; Cholesterol; Nutrition metabolic syndrome; Obesity; Risk factors

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; BILE ACID; BILE ACID BINDING RESIN; COLESTYRAMINE; CYCLOSPORIN; DOCOSAHEXAENOIC ACID; ERYTHROMYCIN; EZETIMIBE; EZETIMIBE PLUS SIMVASTATIN; GEMFIBROZIL; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MEVINOLIN; NICOTINIC ACID; OCTADECANOL; OMEGA 3 FATTY ACID; PRAVASTATIN; RESIN; RETINOL; SIMVASTATIN; STEROL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN D; VITAMIN K GROUP;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTERY INTIMA PROLIFERATION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATHEROSCLEROSIS; BEHAVIOR THERAPY; BEVERAGE; BLOATING; CALORIC INTAKE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD; CHILD NUTRITION; CHOLELITHIASIS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONSTIPATION; DIET THERAPY; DIETARY FIBER; DRUG DOSE TITRATION; DRUG INHIBITION; DRUG SAFETY; DYSLIPIDEMIA; FAMILIAL HYPERCHOLESTEROLEMIA; FAT INTAKE; FLATULENCE; FLUSHING; GASTROINTESTINAL SYMPTOM; GENETIC DISORDER; GLUCOSE TOLERANCE; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERLIPOPROTEINEMIA TYPE 1; HYPERURICEMIA; LIFESTYLE MODIFICATION; LIPID DIET; LIVER FAILURE; METABOLIC SYNDROME X; MUSCLE CRAMP; MYOPATHY; OBESITY; PANCREATITIS; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; PREGNANCY; PRIORITY JOURNAL; REVIEW; RHABDOMYOLYSIS; SIDE EFFECT;

ANTILIPEMIC AGENTS; ATHEROSCLEROSIS; CHILD; DYSLIPIDEMIAS; HUMANS; METABOLIC SYNDROME X; OBESITY;

EID: 59749105624     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2008.11.006     Document Type: Review

References (48)

1. McGill Jr. H.C., McMahan C.A., and Gidding S.S. Preventing heart disease in the 21st century: implications of the pathobiological determinants of atherosclerosis in youth (PDAY) study. Circulation 117 9 (2008) 1216-1227
2. Gidding S. Noninvasive cardiac imaging: implications for risk assessment in adolescents and young adults. Ann Med 40 (2008) 506-513
3. National Institute of Diabetes and Digestive Diseases. National diabetes statistics fact sheet: general information and national estimates on diabetes in the United States (2005), U.S. Department of Health and Human Services, National Institutes of Health, Bethesda (MD)
4. Kaufman F.R. Type 2 diabetes mellitus in children and youth: a new epidemic. J Pediatr Endocrinol Metab 15 Suppl 2 (2002) 737-744
5. McMahan C.A., Gidding S.S., Fayad Z.A., et al. Risk scores predict atherosclerotic lesions in young people. Arch Intern Med 165 8 (2005) 883-890
6. Mahoney L.T., Burns T.L., Stanford W., et al. Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: the Muscatine study. J Am Coll Cardiol 27 2 (1996) 277-284
7. Raitakari O.T., Juonala M., Kahonen M., et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the cardiovascular risk in young Finns study. JAMA 290 17 (2003) 2277-2283
8. Li S., Chen W., Srinivasan S.R., et al. Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa heart study. JAMA 290 17 (2003) 2271-2276
9. McCrindle B.W., Urbina E.M., Dennison B.A., et al. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation 115 14 (2007) 1948-1967
10. Kavey R.E., Allada V., Daniels S.R., et al. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 114 24 (2006) 2710-2738
11. Management of dyslipidemias in children and adolescents with diabetes: consensus statement American Diabetes Association. Diabetes Care 2003;26(7):2194-7.
12. McNamara J.J., Molot M.A., Stremple J.F., et al. Coronary artery disease in combat casualties in Vietnam. JAMA 216 7 (1971) 1185-1187
13. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. A preliminary report from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. JAMA 264 23 (1990) 3018-3024
14. Berenson G.S., Srinivasan S.R., Bao W., et al. The Bogalusa heart study. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med 338 23 (1998) 1650-1656
15. Napoli C., Glass C.K., Witztum J.L., et al. Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: fate of early lesions in children (FELIC) study. Lancet 354 9186 (1999) 1234-1241
16. Cohen J.C., Boerwinkle E., Mosley Jr. T.H., et al. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 354 12 (2006) 1264-1272
17. Gidding S., Chomka E., and Bookstein L. Usefulness of electron beam tomography in adolescents and young adults with heterozygous familial hypercholesterolemia. Circulation 98 (1998) 2580-2583
18. Mietus-Snyder M., and Malloy M.J. Endothelial dysfunction occurs in children with two genetic hyperlipidemias: improvement with antioxidant vitamin therapy. J Pediatr 133 1 (1998) 35-40
19. Tonstad S., Joakimsen O., Stensland-Bugge E., et al. Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects. Arterioscler Thromb Vasc Biol 16 8 (1996) 984-991
20. De Groot E., Hovingh G.K., Zwinderman A.H., et al. Data density curves of B-mode ultrasound arterial wall thickness measurements in unaffected control and at-risk populations. Int Angiol 24 4 (2005) 359-365
21. Raitakari O.T., Ronnemaa T., Jarvisalo M.J., et al. Endothelial function in healthy 11-year-old children after dietary intervention with onset in infancy: the Special Turku Coronary Risk Factor Intervention Project for children (STRIP). Circulation 112 24 (2005) 3786-3794
22. Loria C.M., Liu K., Lewis C.E., et al. Early adult risk factor levels and subsequent coronary artery calcification: the CARDIA Study. J Am Coll Cardiol 49 20 (2007) 2013-2020
23. Obesity: preventing and managing the global epidemic. Report of a WHO consultation 1997.
24. Whitaker R.C., Wright J.A., Pepe M.S., et al. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med 337 13 (1997) 869-873
25. Ford E.S., and Capewell S. Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. J Am Coll Cardiol 50 22 (2007) 2128-2132
26. Weiss R., Dziura J., Burgert T.S., et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350 23 (2004) 2362-2374
27. Morrison J.A., Friedman L.A., and Gray-McGuire C. Metabolic syndrome in childhood predicts adult cardiovascular disease 25 years later: the Princeton Lipid Research Clinics Follow-Up Study. Pediatrics 120 2 (2007) 340-345
28. Jolliffe C.J., and Janssen I. Distribution of lipoproteins by age and gender in adolescents. Circulation 114 10 (2006) 1056-1062
29. National Cholesterol Education Program (NCEP). Highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 89 3 (1992) 495-501
30. Daniels S.R., and Greer F.R. Lipid screening and cardiovascular health in childhood. Pediatrics 122 1 (2008) 198-208
31. Scriver C., Beaudet A., Sly W., et al. In: Stanbury J.B., Wyngaarden J.B., and Fredrickson D.S. (Eds). The metabolic basis of inherited disease. 6th edition (1989), McGraw-Hill Information Services Co., New York
32. Shamir R., Tershakovec A.M., Gallagher P.R., et al. The influence of age and relative weight on the presentation of familial combined hyperlipidemia in childhood. Atherosclerosis 121 1 (1996) 85-91
33. Gidding S.S., Dennison B.A., Birch L.L., et al. Dietary recommendations for children and adolescents: a guide for practitioners. Pediatrics 117 2 (2006) 544-559
34. Obarzanek E., Kimm S.Y., Barton B.A., et al. Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: seven-year results of the Dietary Intervention Study in Children (DISC). Pediatrics 107 2 (2001) 256-264
35. Hakanen M., Lagstrom H., Kaitosaari T., et al. Development of overweight in an atherosclerosis prevention trial starting in early childhood. The STRIP study. Int J Obes (Lond) 30 4 (2006) 618-626
36. Rasanen M., Niinikoski H., Keskinen S., et al. Nutrition knowledge and food intake of seven-year-old children in an atherosclerosis prevention project with onset in infancy: the impact of child-targeted nutrition counselling given to the parents. Eur J Clin Nutr 55 4 (2001) 260-267
37. Becque M.D., Katch V.L., Rocchini A.P., et al. Coronary risk incidence of obese adolescents: reduction by exercise plus diet intervention. Pediatrics 81 5 (1988) 605-612
38. Ludwig D.S., Pereira M.A., Kroenke C.H., et al. Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults. JAMA 282 16 (1999) 1539-1546
39. Kris-Etherton P., Harris W., and Appel L. Omega-3 fatty acids and cardiovascular disease. New recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol 23 (2003) 151-152
40. McCrindle B.W., O'Neill M.B., Cullen-Dean G., et al. Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: a randomized, crossover trial. J Pediatr 130 2 (1997) 266-273
41. Davidson M.H., and Robins on J.G. Safety of aggressive lipid management. J Am Coll Cardiol 49 17 (2007) 1753-1762
42. Kazmin A., Garcia-Bournissen F., and Koren G. Risks of statin use during pregnancy: a systematic review. J Obstet Gynaecol Can 29 11 (2007) 906-908
43. Wiegman A., Hutten B.A., de Groot E., et al. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA 292 3 (2004) 331-337
44. Kastelein J.J., Akdim F., Stroes E.S., et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 358 14 (2008) 1431-1443
45. Coletti R.B., Neufeld E.J., Roff N.K., et al. Niacin treatment of hypercholesterolemia in children. Pediatrics 92 (1993) 78-82
46. Gagne C., Gaudet D., and Bruckert E. Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia. Circulation 105 21 (2002) 2469-2475
47. Engler M.M., Engler M.B., Malloy M.J., et al. Effect of docosahexaenoic acid on lipoprotein subclasses in hyperlipidemic children (the early study). Am J Cardiol 95 7 (2005) 869-871
48. Amundsen A.L., Ntanios F., Put N., et al. Long-term compliance and changes in plasma lipids, plant sterols and carotenoids in children and parents with FH consuming plant sterol ester-enriched spread. Eur J Clin Nutr 58 12 (2004) 1612-1620